Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C17H19N3OS |
| Molecular Weight | 313.417 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C1[C@H]2C[C@@H]3CN(C2)C[C@H]1[C@@H]3OC4=NN=C(S4)C5=CC=CC=C5
InChI
InChIKey=QZDCYUCETTWCMO-WTGKZIDZSA-N
InChI=1S/C17H19N3OS/c1-2-4-12(5-3-1)16-18-19-17(22-16)21-15-13-6-11-7-14(15)10-20(8-11)9-13/h1-5,11,13-15H,6-10H2/t11-,13-,14+,15-
| Molecular Formula | C17H19N3OS |
| Molecular Weight | 313.417 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:39:56 GMT 2025
by
admin
on
Mon Mar 31 20:39:56 GMT 2025
|
| Record UNII |
WX8LOM674D
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL3545231
Created by
admin on Mon Mar 31 20:39:56 GMT 2025 , Edited by admin on Mon Mar 31 20:39:56 GMT 2025
|
PRIMARY | |||
|
300000036951
Created by
admin on Mon Mar 31 20:39:56 GMT 2025 , Edited by admin on Mon Mar 31 20:39:56 GMT 2025
|
PRIMARY | |||
|
1620388-44-4
Created by
admin on Mon Mar 31 20:39:56 GMT 2025 , Edited by admin on Mon Mar 31 20:39:56 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
24795933
Created by
admin on Mon Mar 31 20:39:56 GMT 2025 , Edited by admin on Mon Mar 31 20:39:56 GMT 2025
|
PRIMARY | |||
|
WX8LOM674D
Created by
admin on Mon Mar 31 20:39:56 GMT 2025 , Edited by admin on Mon Mar 31 20:39:56 GMT 2025
|
PRIMARY | |||
|
1026134-63-3
Created by
admin on Mon Mar 31 20:39:56 GMT 2025 , Edited by admin on Mon Mar 31 20:39:56 GMT 2025
|
PRIMARY | |||
|
9998
Created by
admin on Mon Mar 31 20:39:56 GMT 2025 , Edited by admin on Mon Mar 31 20:39:56 GMT 2025
|
PRIMARY | |||
|
1026687-03-5
Created by
admin on Mon Mar 31 20:39:56 GMT 2025 , Edited by admin on Mon Mar 31 20:39:56 GMT 2025
|
ALTERNATIVE | |||
|
C170209
Created by
admin on Mon Mar 31 20:39:56 GMT 2025 , Edited by admin on Mon Mar 31 20:39:56 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
100% conversion to M1
MAJOR
|
||
|
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> AGONIST |
ALPHA 7 IN VITRO DATA: Ki = 27 +/- 0.9 nM
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
EXCRETED UNCHANGED |
URINE
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
10% conversion to M1
|
||
|
EXCRETED UNCHANGED |
FECAL
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
100% conversion to M1
MAJOR
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
2.1% conversion to M1
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
3.2% conversion to M1
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE -> PARENT |
MAJOR
URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
MAJOR
URINE
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Tmax | PHARMACOKINETIC |
|
SINGLE ORAL DOSE |
|
||
| Biological Half-life | PHARMACOKINETIC |
|
SINGLE ORAL DOSE |
|
||